A Single Arm Study of Brain Metastasis in Patients With HER2-positive Breast Cancer
Status:
Recruiting
Trial end date:
2022-06-01
Target enrollment:
Participant gender:
Summary
The aim of this study was to evaluate the progression time and efficacy of brain tumors in
patients with brain metastases from HER2-positive breast cancer treated with Pyrrolidine and
Capecitabine combined with brain radiotherapy.
Phase:
Phase 4
Details
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital